Crystal M. Weyman

809 total citations
26 papers, 658 citations indexed

About

Crystal M. Weyman is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Crystal M. Weyman has authored 26 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Crystal M. Weyman's work include Muscle Physiology and Disorders (10 papers), Cell death mechanisms and regulation (6 papers) and interferon and immune responses (5 papers). Crystal M. Weyman is often cited by papers focused on Muscle Physiology and Disorders (10 papers), Cell death mechanisms and regulation (6 papers) and interferon and immune responses (5 papers). Crystal M. Weyman collaborates with scholars based in United States, India and China. Crystal M. Weyman's co-authors include Alan Wolfman, Elizabeth J. Taparowsky, Curtis L. Ashendel, Girish C. Shukla, Yuxia Mei, Aimin Zhou, Marina Wolfson, Hongli Liu, Wendy Liu and Atossa Shaltouki and has published in prestigious journals such as The Journal of Cell Biology, Cancer Research and Oncogene.

In The Last Decade

Crystal M. Weyman

26 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Crystal M. Weyman United States 15 506 175 84 75 69 26 658
Yichao Fan China 15 486 1.0× 116 0.7× 136 1.6× 86 1.1× 56 0.8× 20 759
Emma C. Ferber United Kingdom 7 616 1.2× 274 1.6× 94 1.1× 140 1.9× 53 0.8× 7 801
Stefania Santopietro Italy 9 481 1.0× 136 0.8× 147 1.8× 57 0.8× 40 0.6× 9 612
Ada Girnita Sweden 16 563 1.1× 195 1.1× 164 2.0× 57 0.8× 51 0.7× 22 823
Noga Gadir United States 10 696 1.4× 186 1.1× 99 1.2× 88 1.2× 50 0.7× 18 871
Daniela Flügel Germany 9 452 0.9× 377 2.2× 134 1.6× 79 1.1× 62 0.9× 9 739
Federica Parodi Italy 12 330 0.7× 164 0.9× 120 1.4× 32 0.4× 44 0.6× 21 566
Jee‐Youn Kim South Korea 13 472 0.9× 236 1.3× 130 1.5× 64 0.9× 76 1.1× 28 696
Mousumi Majumdar United States 9 585 1.2× 208 1.2× 74 0.9× 128 1.7× 67 1.0× 9 872
Kumi Takasawa Japan 14 269 0.5× 121 0.7× 125 1.5× 94 1.3× 48 0.7× 37 570

Countries citing papers authored by Crystal M. Weyman

Since Specialization
Citations

This map shows the geographic impact of Crystal M. Weyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Crystal M. Weyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Crystal M. Weyman more than expected).

Fields of papers citing papers by Crystal M. Weyman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Crystal M. Weyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Crystal M. Weyman. The network helps show where Crystal M. Weyman may publish in the future.

Co-authorship network of co-authors of Crystal M. Weyman

This figure shows the co-authorship network connecting the top 25 collaborators of Crystal M. Weyman. A scholar is included among the top collaborators of Crystal M. Weyman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Crystal M. Weyman. Crystal M. Weyman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bhattarai, Asmita, et al.. (2022). The androgen receptor messenger RNA: what do we know?. RNA Biology. 19(1). 819–828. 11 indexed citations
2.
Bhattarai, Asmita, et al.. (2021). Regulation of cholesterol biosynthesis and lipid metabolism: A microRNA management perspective. Steroids. 173. 108878–108878. 27 indexed citations
3.
4.
Shankar, Eswar, Jagjit Singh, Kavleen Sikand, et al.. (2019). MiR-644a Disrupts Oncogenic Transformation and Warburg Effect by Direct Modulation of Multiple Genes of Tumor-Promoting Pathways. Cancer Research. 79(8). 1844–1856. 38 indexed citations
5.
6.
Weyman, Crystal M., et al.. (2013). Targeting of Androgen Receptor Expression by Andro-miRs as Novel Adjunctive Therapeutics in Prostate Cancer. Journal of Cancer Therapy. 4(4). 47–58. 5 indexed citations
7.
Shaltouki, Atossa, Terri J. Harford, Anton A. Komar, & Crystal M. Weyman. (2013). IRES-mediated translation of the pro-apoptotic Bcl2 family member PUMA. PubMed. 1(1). e24391–e24391. 1 indexed citations
8.
Weyman, Crystal M., et al.. (2009). Non-canonical role for the TRAIL receptor DR5/FADD/caspase pathway in the regulation of MyoD expression and skeletal myoblast differentiation. Differentiation. 78(4). 205–212. 18 indexed citations
9.
Zhou, Yan, Crystal M. Weyman, Hongli Liu, Alexandru Almasan, & Aimin Zhou. (2008). IFN- γ Induces Apoptosis in HL-60 Cells Through Decreased Bcl-2 and Increased Bak Expression. Journal of Interferon & Cytokine Research. 28(2). 65–72. 19 indexed citations
10.
Liu, Hongli, et al.. (2008). Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression. Cancer Chemotherapy and Pharmacology. 63(6). 997–1005. 72 indexed citations
11.
12.
13.
Li, Qing, et al.. (2006). PKCα regulates phosphorylation and enzymatic activity of cPLA2 in vitro and in activated human monocytes. Cellular Signalling. 19(2). 359–366. 22 indexed citations
14.
Karasarides, Maria, et al.. (2006). Active Ras‐induced effects on skeletal myoblast differentiation and apoptosis are independent of constitutive PI3‐kinase activity. Cell Biology International. 30(4). 308–318. 9 indexed citations
15.
16.
17.
18.
Weyman, Crystal M. & Alan Wolfman. (1997). Oncogenic Ras-induced secretion of a novel inhibitor of skeletal myoblast differentiation. Oncogene. 15(21). 2521–2528. 12 indexed citations
19.
Weyman, Crystal M., Melissa B. Ramocki, Elizabeth J. Taparowsky, & Alan Wolfman. (1997). Distinct signaling pathways regulate transformation and inhibition of skeletal muscle differentiation by oncogenic Ras. Oncogene. 14(6). 697–704. 45 indexed citations
20.
Vaidya, Tushar, Crystal M. Weyman, Dorothy Teegarden, Curtis L. Ashendel, & Elizabeth J. Taparowsky. (1991). Inhibition of myogenesis by the H-ras oncogene: implication of a role for protein kinase C.. The Journal of Cell Biology. 114(4). 809–820. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yichao Fan Breakdown of academic impact, for papers by Emma C. Ferber Breakdown of academic impact, for papers by Stefania Santopietro Breakdown of academic impact, for papers by Ada Girnita Breakdown of academic impact, for papers by Noga Gadir Breakdown of academic impact, for papers by Daniela Flügel Breakdown of academic impact, for papers by Federica Parodi Breakdown of academic impact, for papers by Jee‐Youn Kim Breakdown of academic impact, for papers by Mousumi Majumdar Breakdown of academic impact, for papers by Kumi Takasawa
Rankless by CCL
2026